Wageningen, The Netherlands
October 28, 2014
KeyGene announces today it entered into a licence agreement with the University of Edinburgh in the field of Sequence-Based Genotyping (SBG). With this agreement, the University of Edinburgh obtains a non-exclusive licence for the use and application of KeyGene’s patented SBG technology including RAD-Seq (Restriction-site Associated DNA Sequencing) for research purposes.
The SBG technology allows discovery and scoring of genetic variation for improvement of crops without prior knowledge of the genome sequence. By means of this technology genome-wide SNP discovery and genotyping is achieved in a single experiment. KeyGene has developed a strong proprietary position on SBG with world-wide IP protection and an active policy to outlicense the technology. For academic research, licences are offered under favorable and attractive conditions, fostering collaborations and maximizing broad application of SBG.
"Since the first publication of reduced representation, sequence-based genotyping methods such as RAD-Seq, we in Edinburgh Genomics have been keen to make this transformative technology available to all our collaborators across the biological sciences," said Prof. Mark Blaxter, Director of Edinburgh Genomics. "With this licence and the support of KeyGene we will be able to drive further discoveries in crop, animal and environmental science."
Michiel van Eijk, CSO of KeyGene adds: “We are very pleased with licensing the University of Edinburgh in this important research field of next-generation sequencing based genetic marker analysis. We welcome and stimulate the use of SBG technology for research applications by leading organizations such as the University of Edinburgh.”
About KeyGene
25 years of sustainable molecular genetic innovations for crop improvement KeyGene is a privately owned, molecular genetic Ag Biotech company with a primary focus on the improvement of 6F (Food, Feed, Fiber, Fuel, Flowers and Fun) crops. KeyGene supports its strategic partners with cutting edge breeding technologies and plant-based trait platforms, with more than 135 employees from all over the world. KeyGene has its headquarters in Wageningen, the Netherlands, a subsidiary in Rockville, USA and a Joint Lab with the Shanghai Institute of Biological Sciences in Shanghai, China.
About Edinburgh Genomics
Edinburgh Genomics is a major academic genomics and bioinformatics facility, based within the University of Edinburgh. Based on our decades of experience, skilled staff, and cutting-edge installation of data generation and analysis technology, we collaborate with researchers across the biosciences including other academic centres, independent institutes and industry. Edinburgh Genomics has been key to the wide adoption of next-generation genotyping-by sequencing technologies by the wider research community. Edinburgh Genomics is recognised as a UK national facility by the Natural Environment Research Council, the Biomedical and Biotechnology Research Council and the Medical Research Council.
Topics
Species
